Over the past four years, the demand for Research Transnational Access (TNA) within the HITRIplus project has been consistently high. We are pleased to announce that we have now reached the maximum number of research TNA hours committed under the Grant Agreement.

This achievement is a clear sign of the scientific community’s strong interest in advancing hadron therapy research through our infrastructure.

We thank all researchers and institutions who contributed to the great success of this initiative.

The clinical research programme is still active, and we are still welcoming clinical staff who are willing to join one of our clinical facilities to contribute to ongoing studies and gain hands-on experience in particle therapy.

Please stay connected for further project updates at www.hitriplus.eu.